Exploring the Potential Benefits of Probiotic Yogurt
Launched by WECARE PROBIOTICS CO., LTD. · Feb 21, 2025
Trial Information
Current as of June 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special yogurt containing probiotics, which are good bacteria for your gut, can help people with chronic constipation feel better. Over the course of 21 days, researchers will observe whether this yogurt improves constipation symptoms and how it affects the balance of bacteria in the gut. They will also monitor any side effects that participants may experience during the study.
To participate in this trial, you need to be between 18 and 65 years old and meet specific criteria for chronic constipation. However, certain health conditions, like diabetes or pregnancy, or recent use of certain medications, may prevent you from joining. If you decide to participate, you will be asked to regularly consume the yogurt and report your experiences to help researchers understand its effects. This study is currently recruiting participants, so it’s a great opportunity for those seeking relief from chronic constipation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Meet the Rome IV diagnosis criteria for chronic constipation;
- • 2. Patients who are able to understand clinical studies and are committed to complying with study requirements and procedures;
- • 3. Age 18-65. -
- Exclusion Criteria:
- • 1. Systemic (diabetes, autoimmune diseases, cancer), gastrointestinal or liver diseases known to be associated with alterations in the gut microbiota;
- • 2. Patients who are pregnant or lactating;
- • 3. have taken antimicrobials, probiotics, or drugs that inhibit stomach acid or gastrointestinal motility in the past 6 weeks;
- • 4. Patients who changed their diet type during the study;
- • 5. Patients who are allergic or intolerant to any component of the investigational product formulation;
- • 6. Patients with cardiovascular, cerebrovascular, liver, kidney and hematopoietic system and other serious diseases and endocrine diseases, mental patients;
- • 7. Stop taking the tested sample or add other drugs in the middle, unable to judge the efficacy or incomplete data;
- • 8. short-term use of objects related to the function of the test, affecting the judgment of the result;
- • 9. have been dieting, exercising excessively, taking weight loss medications or taking medications that may affect appetite in the past 3 months;
- • 10. Current or past excessive use of alcohol, drugs, or supplements that may cause intestinal dysfunction or interfere with the evaluation of the efficacy of the study product -
About Wecare Probiotics Co., Ltd.
wecare probiotics co., ltd. is a leading biotechnology firm dedicated to advancing gut health through innovative probiotic solutions. With a robust portfolio of research and development initiatives, the company focuses on formulating high-quality probiotic products that are backed by scientific evidence. Committed to enhancing the well-being of individuals, wecare probiotics collaborates with healthcare professionals and academic institutions to conduct clinical trials that evaluate the efficacy and safety of its formulations. The company's mission is to empower consumers with effective, research-driven probiotic options, fostering a healthier future for all.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suzhou, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported